Adversities in adherence to endocrine therapy for breast cancer may compromise treatment and survival: an observational study. Acervo Saúde [Internet]. 2025 Oct. 31 [cited 2026 Nov. 3];25(10):e21686. Available from: https://acervomais.com.br/saude/article/view/21686